You are here
Clinical Trials: Stroke and Related
Each Clinical Trial will open in a new browser window or tab.
Condition: Chronic Stroke
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Conditions: Cerebral Ischemia; Cerebral Infarction; Stroke, Acute
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Conditions: Stroke; Umbilical Cord Blood; Erythropoietin; Safety; Treatment Outcome
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Conditions: Subcortical Vascular Dementia; Cerebral Small Vessel Diseases
Interventions: Drug: NBP; Drug: Placebos
Sponsor: Tianjin Medical University General Hospital
Recruiting
Interventions: Drug: NBP; Drug: Placebos
Sponsor: Tianjin Medical University General Hospital
Recruiting
Condition: Acute Ischemic Stroke
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Condition: Stroke, Ischemic
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Conditions: Alzheimer Disease; Alzheimer Dementia; Vascular Dementia; Lewy Body Disease; Lewy Body Dementia With Behavioral Disturbance (Disorder); Dementia, Mixed; Parkinson-Dementia Syndrome; Chronic Traumatic Encephalopathy; Huntington's Dementia; Wernicke Korsakoff Syndrome; Traumatic Brain Injury; Dementia, Multi-Infarct; Autism; Autism Spectrum Disorder; Autistic Behavior; Autistic Disorder, Current or Active State
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Conditions: Ischemic Stroke; Chronic Stroke; Hemiparesis; Arm Paralysis
Interventions: Combination Product: CTX0E03 Drug Product and delivery device; Drug: Placebo
Sponsor: ReNeuron Limited
Not yet recruiting
Interventions: Combination Product: CTX0E03 Drug Product and delivery device; Drug: Placebo
Sponsor: ReNeuron Limited
Not yet recruiting
Condition: Stroke
Intervention: Device: Virtual Reality Mirror Therapy
Sponsors: Columbia University; Realiteer Corp.
Recruiting
Intervention: Device: Virtual Reality Mirror Therapy
Sponsors: Columbia University; Realiteer Corp.
Recruiting
Condition: Stroke
Interventions: Drug: Adipose derived Stem Cell; Drug: placebo
Sponsors: University Hospital, Grenoble; European Commission H2020 program; University Grenoble Alps; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Andaluz Health Service; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; CH Sainte-Anne, Paris, France
Recruiting
Interventions: Drug: Adipose derived Stem Cell; Drug: placebo
Sponsors: University Hospital, Grenoble; European Commission H2020 program; University Grenoble Alps; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Andaluz Health Service; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; CH Sainte-Anne, Paris, France
Recruiting
